ESC 2025 29 August - 1 September 2025

Semaglutide effects on incidence and reoccurrence of atrial fibrillation in the SELECT trial

Sorry! It looks like the page you are trying to access contains materials that are still under embargo. Please come back and check again later.
Keywords
Cardiovascular Disease
Congress oral presentation
GLP-1 RA
Semaglutide
PHASE 3 (RCT)